Evidence map›Paper›PMID 34333643›Full record

ArticleThe Journal of clinical endocrinology and metabolism2021

Placental miR-3940-3p Is Associated With Maternal Insulin Resistance in Late Pregnancy.

Fernanda Alvarado-Flores, Tomoko Kaneko-Tarui, William Beyer, Jacqueline Katz, Tianjiao Chu, Patrick Catalano, Yoel Sadovsky, Marie-France Hivert, Perrie O'Tierney-Ginn

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Placental miR-3940-3p Is Associated With Maternal Insulin Resistance in Late Pregnancy.The Journal of clinical endocrinology and metabolism · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Fernanda Alvarado-FloresMother Infant Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
Tomoko Kaneko-TaruiMother Infant Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
William BeyerMother Infant Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
Jacqueline KatzMother Infant Research Institute, Tufts Medical Center, Boston, MA 02111, USA.
Tianjiao ChuMagee Womens Research Institute, Pittsburgh, PA 15213, USA.
Patrick CatalanoMother Infant Research Institute, Tufts Medical Center, Boston, MA 02111, USA.ORCID 0000-0003-1276-7017
Yoel SadovskyMagee Womens Research Institute, Pittsburgh, PA 15213, USA.
Marie-France HivertDepartment of Population Medicine, Harvard Medical School; Harvard Pilgrim Health Care Institute, Boston, MA 02115, USA.
Perrie O'Tierney-GinnMother Infant Research Institute, Tufts Medical Center, Boston, MA 02111, USA.ORCID 0000-0001-5752-4874
Tufts Medical Center · USMagee-Womens Research Institute · USHarvard University · US

Funding

Placental mRNA profiles associated with maternal insulin resistance and fetal adiposity: maternal-placental crosstalkR01HD091735 · NICHD · TUFTS MEDICAL CENTER · PI O'TIERNEY-GINN, PERRIE F · 2017 to 2020
$1.9M
NICHD NIH HHS R01 HD091735NIH HHS R01HD091735
6 · The paper itself

Abstract

contextAn increase in maternal insulin resistance (IR) during pregnancy is essential for normal fetal growth. The mechanisms underlying this adaptation are poorly understood. Placental factors are believed to instigate and maintain these changes, as IR decreases shortly after delivery. Methylation of placental gene loci that are common targets for miRNAs are associated with maternal IR.

objectiveWe hypothesized that placental miRNAs targeting methylated loci are associated with maternal IR during late pregnancy.

methodsWe collected placentas from 132 elective cesarean sections and fasting blood samples at delivery to estimate maternal homeostasis model assessment of insulin resistance (HOMA-IR). Placental miRNA expression was measured via whole genome small-RNA sequencing in a subset of 40 placentas selected by maternal pre-gravid body mass index (BMI) and neonatal adiposity. Five miRNAs correlated with maternal HOMA-IR and previously identified as targeting methylated genes were selected for validation in all 132 placenta samples via RT-qPCR. Multiple regression adjusted for relevant clinical variables.

resultsMedian maternal age was 27.5 years, with median pre-pregnancy BMI of 24.7 kg/m2, and median HOMA-IR of 2.9. Among the 5 selected miRNA, maternal HOMA-IR correlated with the placental expression of miRNA-371b-3p (r = 0.25; P = 0.008) and miRNA-3940-3p (r = 0.32; P = 0.0004) across the 132 individuals. After adjustment for confounding variables, placental miRNA-3940-3p expression remained significantly associated with HOMA-IR (β = 0.16; P = 0.03).

conclusionPlacental miRNA-3940-3p was associated with maternal IR at delivery. This placental miRNA may have an autocrine or paracrine effect-regulating placental genes involved in modulating maternal IR.

Indexed as

Body Mass IndexGene Regulatory NetworksInsulin ResistanceAdultBiomarkersFemaleFollow-Up StudiesGene Expression ProfilingHumansMicroRNAsPlacentaPregnancyPrognosisTrophoblastsBiomarkersMicroRNAsMIRN3940 microRNA, humanHOMA-IRinsulin resistancemiRNAmiRNA-3940-3pplacenta

Identifiers

PMID34333643
PMCPMC8787748
OpenAlexW3190871644

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.